{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:52:09Z","timestamp":1791503529284,"version":"4.3.4"},"reference-count":47,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012921","name":"Royal College of Surgeons in Ireland","doi-asserted-by":"publisher","award":["Clement Archer Scholarship"],"award-info":[{"award-number":["Clement Archer Scholarship"]}],"id":[{"id":"10.13039\/100012921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Health Expectations"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Existing interventions to reduce long\u2010term benzodiazepine receptor agonist (BZRA) use lack theoretical underpinning and detailed descriptions. This creates difficulties in understanding how interventions work and how to replicate them in practice. The Theoretical Domains Framework (TDF) can be used to identify behaviour change determinants to target during intervention development.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To explore barriers and facilitators to discontinuing BZRA use from the perspective of both current and previous long\u2010term BZRA users.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design\/Setting and Participants<\/jats:title><jats:p>Semistructured TDF\u2010based interviews were conducted with community\u2010based individuals with current or previous experience of long\u2010term BZRA use. Data were recorded, transcribed and analysed using the framework method.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty\u2010eight individuals were interviewed. Despite commonalities in perceived barriers\/facilitators to discontinuing BZRA use within individual TDF domains, individual participants had different experiences of identified determinants of BZRA discontinuation. For example, both similarities and differences existed within and between each participant group in terms of knowledge of the\u00a0appropriate duration of BZRA use (\u2018Knowledge\u2019 domain) and experience of withdrawal symptoms (\u2018Reinforcement\u2019 domain). Compared to previous users, current users typically anticipated more barriers to discontinuing BZRA use and fewer positive consequences of discontinuation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study reports on barriers and facilitators to discontinuing BZRA use from the perspectives of current and previous long\u2010term users. The findings highlight the challenging nature of BZRA discontinuation and a multitude of barriers that impact participants\u2019 behaviour regarding BZRA use. Future work will involve developing a theory\u2010based intervention to support BZRA discontinuation in primary care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patient Contribution<\/jats:title><jats:p>The study included patients as participants.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hex.13392","type":"journal-article","created":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T05:54:28Z","timestamp":1638597268000},"page":"355-365","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["\u2018I just thought that it was such an impossible thing\u2019: A qualitative study of barriers and facilitators to discontinuing long\u2010term use of benzodiazepine receptor agonists using the Theoretical Domains Framework"],"prefix":"10.1111","volume":"25","author":[{"given":"Tom","family":"Lynch","sequence":"first","affiliation":[{"name":"School of Pharmacy and Biomolecular Sciences Royal College of Surgeons in Ireland Dubin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crist\u00edn","family":"Ryan","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences Trinity College Dublin Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8778-0112","authenticated-orcid":false,"given":"Cathal A.","family":"Cadogan","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences Trinity College Dublin Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,12,3]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113503509"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-013-0292-0"},{"issue":"5","key":"e_1_2_9_4_1","first-page":"339","article-title":"Deprescribing benzodiazepine receptor agonists: evidence\u2010based clinical practice guideline","volume":"64","author":"Pottie K","year":"2018","journal-title":"Can Fam Physician"},{"key":"e_1_2_9_5_1","doi-asserted-by":"crossref","unstructured":"Benzodiazepine Committee. Benzodiazepines: good practice guidelines for clinicians. Department of Health and Children Dublin Ireland.2002. Accessed January 6 2021.https:\/\/www.drugsandalcohol.ie\/5349\/","DOI":"10.26420\/jpediatriendocrinol.2021.1045"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2015.09.003"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13570"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2015.055"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.yco.0000165594.60434.84"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2005.07.016"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-017-0207-7"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-020-03063-z"},{"key":"e_1_2_9_13_1","first-page":"CD009652","article-title":"Psychosocial interventions for benzodiazepine harmful use, abuse or dependence","volume":"5","author":"Darker CD","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_14_1","first-page":"CD011481","article-title":"Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users","volume":"3","author":"Baandrup L","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14981"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-7-38"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40814-019-0425-6"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2012.09.010"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-016-0182-z"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/qshc.2004.011155"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-7-37"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-017-0605-9"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-015-0349-3"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-117"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/1049732305276687"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-015-0019-8"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/hex.12595"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-020-03007-7"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp08X299290"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/01634372.2014.901470"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-14-191"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-006-0021-3"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02364.x"},{"key":"e_1_2_9_35_1","unstructured":"The Royal Australian College of General Practitioners. Prescribing drugs of dependence in general practice part B\u2014benzodiazepines. The Royal Australian College of General Practitioners.2015. Accessed\u00a0 January 6 2021.https:\/\/www.drugsandalcohol.ie\/24380\/"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-018-0544-4"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.189.3.213"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.02933.x"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03087.x"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1611832"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/wmh3.217"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1017\/ipm.2018.12"},{"key":"e_1_2_9_43_1","unstructured":"Health Service Executive\u2014National Counselling Service\u2014CIPC National Research Group. Counselling in primary care service NES Phase 1. Health Service Executive Dublin. 2018. Accessed January 6 2021.https:\/\/www.hse.ie\/eng\/services\/list\/4\/mental-health-services\/counsellingpc\/cipc-national-evaluation\/hse-ncs-counselling-in-primary-care-national-evaluation-study-report-of-phase-1-april-2018.pdf"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/inm.12894"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125320981174"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125321991274"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.5698"},{"key":"e_1_2_9_48_1","doi-asserted-by":"crossref","unstructured":"DoodyPWM ScarlettS HeverA O'MahoneyP KennyR. Internet access and use among adults aged 50 and over in Ireland: results from Wave 5 of The Irish Longitudinal Study on Ageing. TILDA; Trinity College Dublin.2020. Accessed January 6 2021.https:\/\/tilda.tcd.ie\/publications\/reports\/pdf\/Report_Covid19InternetReport.pdf","DOI":"10.38018\/TildaRe.2020-06"}],"container-title":["Health Expectations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hex.13392","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/hex.13392","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hex.13392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T15:47:18Z","timestamp":1693151238000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hex.13392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,3]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1111\/hex.13392"],"URL":"https:\/\/doi.org\/10.1111\/hex.13392","archive":["Portico"],"relation":{},"ISSN":["1369-6513","1369-7625"],"issn-type":[{"value":"1369-6513","type":"print"},{"value":"1369-7625","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,3]]},"assertion":[{"value":"2021-06-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}